Monitor for any subsequent prospectus supplement or takedown announcement that would indicate an actual offering and its size. Until then, the shelf creates theoretical overhang but no immediate dilution. A near-term secondary could pressure VALN shares; a lack of activity would be neutral.
VALN drugs
VALN drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 17 $5.35entry
- T+1 · 5mo ago +0.56%α −0.22% · $5.38
- T+5 · 5mo ago −2.24%α −1.20% · $5.23
- T+20 · 4mo ago −5.05%α −6.36% · $5.08
- T+60 · 2mo ago +24.49%α +21.34% · $6.66
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Valneva SE's SEC registration statement (F-3, File No. 333-296504) became effective as of June 16, 2026, allowing the company to offer and sell securities (likely common shares or other securities) from time to time. This does not indicate an immediate offering but creates potential dilution overhang that may weigh on the stock until any specific offering is announced and/or completed.
Key Facts
- Form EFFECT for F-3 registration statement filed by Valneva SE
- Effectiveness date: June 16, 2026
- SEC File No. 333-296504
- Shelf registration, no specific offering size, pricing, or terms disclosed
Financial Impact
Undisclosed shelf registration; no offering amount or terms provided. Potential future dilution is indeterminate without further disclosure.
Risk Factors
- Potential future dilution if securities are offered under the shelf
- No specific deal catalyst or timeline provided, uncertainty about capital raise plans
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-002019 |
| Document: 9999999995-26-002019-index.html | 9999999995-26-002019 |
| Document: 9999999995-26-002019.txt | 9999999995-26-002019 |
Track record
9 reports on VALN
Filters
- Nov 13, 20263d ago 6-K Neutral 4/10 Entry $5.66 Now $5.65 −0.18% settles Dec 14
- Nov 6, 202610d ago 6-K Neutral 2/10 Entry $5.51 Now $5.65 +2.54% settles Dec 7
- Oct 15, 20264w ago 6-K Neutral 2/10 Entry $5.91 to $5.76 Now $5.65 −4.40% ▼ −2.54% −0.64% vs SPY
- Oct 8, 20265w ago 6-K Neutral 3/10 Entry $5.69 to $5.64 Now $5.65 −0.70% ▼ −0.88% +4.41% vs SPY
- Jun 17, 202621w ago EFFECT Neutral 3/10 Viewing Entry $5.35 to $5.08 Now $5.65 +5.61% ▼ −5.05% −6.36% vs SPY
- Jun 5, 202623w ago 6-K Neutral 2/10 Entry $5.48 to $5.40 Now $5.65 +3.10% ▼ −1.46% −3.32% vs SPY
- Jun 1, 202624w ago 6-K Neutral 2/10 Entry $5.95 to $5.23 Now $5.65 −5.04% ▼ −12.10% −10.80% vs SPY
- May 5, 202627w ago 6-K Neutral 2/10 Entry $5.29 to $5.63 Now $5.65 +6.81% ▲ +6.43% +1.47% vs SPY
- Mar 26, 202633w ago 6-K Neutral 3/10 Entry $6.32 to $5.50 Now $5.65 −10.60% ▼ −12.97% −23.64% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers